Novel dry powder inhalation system based on dispersion of lyophilisates

European Journal of Pharmaceutical Sciences

Volumn 43, Issue 1-2, 2011, Pages 32-40

  Claus, Sarah ^a   Schoenbrodt, Tilo ^b   Weiler, Claudius ^b   Friess, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Andersen cascade impactor; Dry powder inhalation; Freeze drying; Lyophilisate; Particle size distribution; Time of flight

Indexed keywords

AMINO ACID; EXCIPIENT; SUGAR;

AEROSOL; AIRBORNE PARTICLE; ARTICLE; COMPRESSED AIR; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRY POWDER; FREEZING; LASER DIFFRACTION; LYOPHILISATE; METERED DOSE INHALER; MICROSCOPY; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; X RAY DIFFRACTION;

ADMINISTRATION, INHALATION; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; COMPRESSED AIR; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; EQUIPMENT DESIGN; EXCIPIENTS; FREEZE DRYING; MODELS, THEORETICAL; PARTICLE SIZE; PHENYLALANINE; POWDERS; VALINE;

EID: 79955686950     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.03.005     Document Type: Article

References (32)

1. A.A. Barresi, R. Pisano, V. Rasetto, D. Fissore, and D.L. Marchisio Model-based monitoring and control of industrial freeze-drying processes: effect of batch nonuniformity Drying Technol. 28 2010 577 590
2. Y.S. Cheng, E.B. Barr, I.A. Marshall, and J.P. Mitchell Calibration and performance of an API Aerosizer J. Aerosol Sci. 24 1993 501 514
3. N.Y.K. Chew, and H.-K. Chan The role of particle properties in pharmaceutical powder inhalation formulations J. Aerosol Med. 15 2002 325 330 (Pubitemid 34983138)
4. M.B. Chougule, B.K. Padhi, K.A. Jinturkar, and A. Misra Development of dry powder inhalers Recent. Pat. Drug Deliv. Formul. 1 2007 11 21
5. A. Chow, H. Tong, P. Chattopadhyay, and B. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437 (Pubitemid 46295160)
6. T.M. Crowder, J.A. Rosati, J.D. Schroeter, A.J. Hickey, and T.B. Martonen Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development Pharm. Res. 19 2002 239 245 (Pubitemid 34211838)
7. A.H. De Boer, D. Gjaltema, P. Hagedoorn, and H.W. Frijlink Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique Int. J. Pharm. 249 2002 219 231 (Pubitemid 35333448)
8. A.H. De Boer, D. Gjaltema, P. Hagedoorn, and H.W. Frijlink Comparative in vitro performance evaluation of the Novopulmon® 200 Novolizer® and Budesonid-ratiopharm® Jethaler: two novel budesonide dry powder inhalers Pharmazie 59 2004 692 699 (Pubitemid 39281007)
9. F. Franks Freeze-drying of bioproducts: putting principles into practice Eur. J. Pharm. Biopharm. 45 1998 221 229 (Pubitemid 28270810)
10. D. Hochrainer, H. Hölz, C. Kreher, L. Scaffidi, M. Spallek, and H. Wachtel Comparison of the aerosol velocity and spray duration of Respimat® Soft Mist™ inhaler and pressurized metered dose inhalers J. Aerosol Med. 18 2005 273 282 (Pubitemid 41395729)
11. K. Inthavong, J. Wen, Z. Tian, and J. Tu Numerical study of fibre deposition in a human nasal cavity J. Aerosol Sci. 39 2008 253 265
12. N. Islam, and E. Gladki Dry powder inhalers (DPIs) - a review of device reliability and innovation Int. J. Pharm. 360 2008 1 11
13. K.-I. Izutsu, and S. Kojima Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying J. Pharm. Pharmacol. 54 2002 1033 1039
14. A.I. Kim, M.J. Akers, and S.L. Nail The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute J. Pharm. Sci. 87 1998 931 935 (Pubitemid 28381249)
15. J.P. Mitchell, and M.W. Nagel Time-of-flight aerodynamic particle sizer analyzers: their use and limitations for the evaluation of medical aerosols J. Aerosol Med. 12 1999 217 240
16. J.P. Mitchell, and M.W. Nagel Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations J. Aerosol Med. 16 2003 341 377 (Pubitemid 38120942)
17. R. Mohan, K.-K. Koo, C. Strege, and A.S. Myerson Effect of additives on the transformation behavior of l-phenylalanine in aqueous solution Ind. Eng. Chem. Res. 40 2001 6111 6117 (Pubitemid 34015081)
18. S.P. Newman, and S.W. Clarke Therapeutic aerosols 1-physical and practical considerations Thorax 38 1983 881 886 (Pubitemid 14213229)
19. B.J. O'connor The ideal inhaler: design and characteristics to improve outcomes Respir. Med. 98 2004 S10 S16
20. B. Olsson, L. Asking, and M. Year Johansson Choosing a cascade impactor R.N. Dalby, P.R. Byron, S.J. Farr, Respiratory Drug Delivery VI 1998 Interpharm Press Buffalo Grove, IL 133 138
21. C. Parlati, P. Colombo, F. Buttini, P. Young, H. Adi, A. Ammit, and D. Traini Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency Pharm. Res. 26 2009 1084 1092
22. E. Pharmacopoeia Section 2.9.18 - preparation for inhalation: aerodynamic assessment of fine particles, Strasbourg 2008 France Council of Europe
23. Y. Roos, and M. Karel Plasticizing effect of water on thermal behavior and crystallization of amorphous food models J. Food Sci. 56 1991 38 43
24. J.A. Searles, J.F. Carpenter, and T.W. Randolph The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf J. Pharm. Sci. 90 2001 860 871 (Pubitemid 32645944)
25. B. Shekunov, P. Chattopadhyay, H. Tong, and A. Chow Particle size analysis in pharmaceutics: principles, methods and applications Pharm. Res. 24 2007 203 227 (Pubitemid 46072181)
26. I.J. Smith, and M. Parry-Billings The inhalers of the future? A review of dry powder devices on the market today Pulm. Pharmacol. Ther. 16 2003 79 95 (Pubitemid 36372063)
27. R. Vanbever, J.D. Mintzes, J. Wang, J. Nice, D. Chen, R. Batycky, R. Langer, and D.A. Edwards Formulation and physical characterization of large porous particles for inhalation Pharm. Res. 16 1999 1735 1742 (Pubitemid 29530407)
28. K. Wetterlin Turbuhaler: a new powder inhaler for administration of drugs to the airways Pharm. Res. 5 1988 506 508
29. S. White, D.B. Bennett, S. Cheu, P.W. Conley, D.B. Guzek, S. Gray, J. Howard, R. Malcolmson, J.M. Parker, P. Roberts, N. Sadrzadeh, J.D. Schumacher, S. Seshadri, G.W. Sluggett, C.L. Stevenson, and N.J. Harper EXUBERA®: pharmaceutical development of a Novel Product for pulmonary delivery of insulin Diabetes Technol. Ther. 7 2005 896 906 (Pubitemid 43133996)
30. Yamashita, C., Ibaragi, S., Fukunaga, Y., Akagi, A., 2004. Dry powder inhalation system for transmulmonary administration. EP02736105.
31. P.M. Young, J. Thompson, R. Price, D. Woodcock, and K. Davies The use of a novel handheld device to deliver high respirable fractions of high-dose dry powder active agents to the lung J. Aerosol Med. 16 2003 192
32. P.M. Young, J. Thompson, D. Woodcock, M. Aydin, and R. Price The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the delivery of pumactant for inhalation therapy J. Aerosol Med. 17 2004 123 128 (Pubitemid 38955672)